You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0089: A Two-Stage, Phase Ii, Multi-Center Pilot Study of Intravenous Paclitaxel, Carboplatin, and Bevaci-Zumab Followed By Paclitaxel and Bevacizumab Consolidation Therapy in Patients with Newly Diagnosed Stage Iii/Iv Epithelial Ovarian, Fallopian Tube, …

Article info

Article menu
Download PDFPDF
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0089: A Two-Stage, Phase Ii, Multi-Center Pilot Study of Intravenous Paclitaxel, Carboplatin, and Bevaci-Zumab Followed By Paclitaxel and Bevacizumab Consolidation Therapy in Patients with Newly Diagnosed Stage Iii/Iv Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Authors

Citation

Micha JP, Goldstein BH, Graham CL, et al
0089: A Two-Stage, Phase Ii, Multi-Center Pilot Study of Intravenous Paclitaxel, Carboplatin, and Bevaci-Zumab Followed By Paclitaxel and Bevacizumab Consolidation Therapy in Patients with Newly Diagnosed Stage Iii/Iv Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
International Journal of Gynecologic Cancer 2006;16:625.
Online issue publication 
December 17, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2006 IGCS, International Journal of Gynecological Cancer